Tekcapital Plc (AIM:TEK, OTCQB:TEKCF) will present at the Planet MicroCap Showcase: VIRTUAL 2021 on April 21, 2021, at 9:30 AM ET. Dr. Clifford M. Gross, Executive Chairman, will lead the presentation and answer investor questions. Tekcapital focuses on commercializing university-developed technology through its portfolio in various sectors, including respiratory devices and smart eyewear. Investors can register for 1-on-1 meetings and watch the presentation online.
For more details, visit www.tekcapital.com.
Tekcapital plc announced that its portfolio company, Belluscura plc, has received 510(k) Clearance from the U.S. FDA for its innovative X-PLO2R™ Portable Oxygen Concentrator. This device delivers up to 95% pure oxygen, weighing less than 3.25 lbs, aimed at improving the lives of those with chronic lung diseases, including COPD and COVID-19 related respiratory issues. Belluscura, which holds 18 patents in oxygen generation, anticipates launching the device in 2021. Tekcapital owns approximately 17.8% of Belluscura and holds options for further shares, enhancing their investment potential.
Tekcapital Plc (AIM: TEK, OTCQB: TEKCF) announces that its portfolio company, Salarius Ltd’s subsidiary MicroSalt Inc., is initiating an equity crowdfund on microventures.com to raise up to US$750,000, having already secured US$188K. The funds will support growth and innovation strategies. Additionally, MicroSalt has secured a distributor for low-sodium tortilla chips and will introduce new 1oz SaltMe! products to enhance Amazon competitiveness. MicroSalt’s patented low-sodium salt delivers better health benefits while retaining flavor.
Tekcapital Plc (AIM: TEK, OTCQB: TEKCF) announced that its shares will start cross-trading on the US OTCQB Venture Market effective February 1, 2021. While maintaining its primary listing on the AIM Market of the London Stock Exchange, this initiative will allow US investors to trade Tekcapital shares in USD during US market hours. The company is not conducting a fundraising related to this cross-listing and continues to comply with AIM disclosure requirements. The move aims to enhance visibility and accessibility for US investors.